Loading data
CELHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.52 bn USD | 1.36 bn USD | 1.32 bn USD | 653.6 m USD | 314.27 m USD |
| Cost of revenue | 1.25 bn USD | 675.42 m USD | 684.88 m USD | 382.74 m USD | 186.1 m USD |
| Gross profit | 1.27 bn USD | 680.21 m USD | 633.14 m USD | 270.87 m USD | 128.17 m USD |
| Research and development expense | 2.4 m USD | 1 m USD | 1.7 m USD | 400 k USD | 1 m USD |
| Selling, general and administrative expense | 798.81 m USD | 524.48 m USD | 366.77 m USD | 428.67 m USD | — |
| Operating profit | 141.06 m USD | 155.73 m USD | 266.37 m USD | -157.8 m USD | -4.09 m USD |
| Profit before tax | 125.03 m USD | 195.05 m USD | 291.75 m USD | -152.66 m USD | -4.06 m USD |
| Income tax expense | 17.03 m USD | 49.98 m USD | 64.95 m USD | 34.62 m USD | -8 m USD |
| Net income (reported basis) | 108 m USD | 145.07 m USD | 226.8 m USD | -187.28 m USD | 3.94 m USD |
| Net income attributable to common shareholders | 63.84 m USD | 107.46 m USD | 181.99 m USD | -198.81 m USD | 3.94 m USD |
| Basic earnings per share | 0.25 USD/share | 0.46 USD/share | 0.79 USD/share | -0.88 USD/share | 0.02 USD/share |
| Diluted earnings per share | 0.25 USD/share | 0.45 USD/share | 0.77 USD/share | -0.88 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.